The Effects of Physicians’ Financial Transfers from Drug Firms on Prescribing of Physician-Administered Cancer Drugs
Cost & Quality / Prescription Drugs
Colleen Carey, Cornell University
Jan 01, 2023 - Dec 31, 2023
Summary of the Project:
Physicians commonly receive marketing-related payments from drug firms. This research team will examine the impact of this practice on the prescribing of physician-administered cancer drugs in Medicare and the effect on cancer patients’ mortality rates. The study may inform ongoing policies at hospitals on drug firms’ physician-directed marketing guidelines, as well as changes to the prescribing and payment of cancer drugs in Medicare.